Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE: Safety Overview

Metric BOTULINUM TOXIN TYPE A BREMELANOTIDE
Total FAERS Reports 3,742 718
Deaths Reported 1,288 1
Death Rate 34.4% 0.1%
Hospitalizations 1,536 6
Average Patient Age 44.1 yrs 48.2 yrs
% Female Patients 78.8% 94.8%
FDA Approval Date N/A Jun 21, 2019
Manufacturer Evolus, Inc. Palatin Technologies
Route INTRAMUSCULAR SUBCUTANEOUS
Marketing Status N/A Prescription